| Primary |
| Depression |
11.4% |
| Tetanus |
11.4% |
| Insomnia |
9.5% |
| Drug Use For Unknown Indication |
8.6% |
| Subcutaneous Abscess |
8.6% |
| Hypertension |
5.7% |
| Prophylaxis |
5.7% |
| Sedation |
5.7% |
| Premedication |
4.8% |
| Arrhythmia |
3.8% |
| Convulsion |
3.8% |
| Hyperlipidaemia |
3.8% |
| Status Epilepticus |
3.8% |
| Convulsion Prophylaxis |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Anaesthesia |
1.9% |
| Endoscopy |
1.9% |
| Upper Respiratory Tract Inflammation |
1.9% |
| Analgesic Therapy |
1.0% |
| Angina Pectoris |
1.0% |
|
| Respiratory Depression |
29.8% |
| Stomach Discomfort |
8.5% |
| Pulmonary Embolism |
6.4% |
| Thrombophlebitis |
6.4% |
| Hepatic Failure |
4.3% |
| Hepatitis Fulminant |
4.3% |
| Liver Disorder |
4.3% |
| Medication Error |
4.3% |
| Pancreatitis |
4.3% |
| Pancytopenia |
4.3% |
| Renal Failure Acute |
4.3% |
| Amnesia |
2.1% |
| Anaphylactic Shock |
2.1% |
| Anterograde Amnesia |
2.1% |
| Asthma |
2.1% |
| Cognitive Disorder |
2.1% |
| Convulsion |
2.1% |
| Lymphadenitis |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Platelet Count Decreased |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.8% |
| Kawasaki's Disease |
17.5% |
| Convulsion |
10.5% |
| Insomnia |
8.7% |
| Prophylaxis |
7.0% |
| Depression |
5.2% |
| Analgesic Effect |
3.5% |
| Epidural Anaesthesia |
3.5% |
| Bacterial Infection |
3.1% |
| Bronchoscopy |
2.6% |
| Premedication |
2.6% |
| Epilepsy |
2.2% |
| Anaesthetic Premedication |
1.7% |
| General Anaesthesia |
1.7% |
| Neuroleptic Malignant Syndrome |
1.7% |
| Status Epilepticus |
1.7% |
| Atrial Fibrillation |
1.3% |
| Hyperlipidaemia |
1.3% |
| Reflux Oesophagitis |
1.3% |
| Cardiac Failure |
0.9% |
|
| Pancytopenia |
15.0% |
| Liver Disorder |
12.5% |
| Vitamin K Deficiency |
12.5% |
| Nausea |
7.5% |
| Rash |
7.5% |
| Renal Failure |
7.5% |
| Medication Error |
5.0% |
| Parkinsonism |
5.0% |
| Pregnancy |
5.0% |
| Somnolence |
5.0% |
| Anaphylactic Shock |
2.5% |
| Foetal Exposure During Pregnancy |
2.5% |
| Liver Function Test Abnormal |
2.5% |
| Oxygen Saturation Decreased |
2.5% |
| Respiratory Arrest |
2.5% |
| Thrombophlebitis |
2.5% |
| Vasculitis |
2.5% |
|
| Concomitant |
| Depression |
14.1% |
| Prophylaxis |
10.7% |
| Insomnia |
9.9% |
| Chronic Hepatitis C |
7.0% |
| Drug Use For Unknown Indication |
6.8% |
| Schizophrenia |
4.7% |
| Product Used For Unknown Indication |
4.4% |
| Convulsion |
4.2% |
| Parkinson's Disease |
4.2% |
| Simple Partial Seizures |
4.2% |
| Pain |
3.6% |
| Pneumonia |
3.6% |
| Hypertension |
3.4% |
| Behcet's Syndrome |
3.1% |
| Osteoporosis |
3.1% |
| Premedication |
3.1% |
| Sedation |
3.1% |
| Duodenal Ulcer Perforation |
2.3% |
| Epilepsy |
2.3% |
| Acute Respiratory Distress Syndrome |
2.1% |
|
| Feeling Abnormal |
10.3% |
| Tremor |
7.4% |
| Hyponatraemia |
5.9% |
| Pyrexia |
5.9% |
| Urine Output Decreased |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Xeroderma |
5.9% |
| Completed Suicide |
4.4% |
| Hepatic Function Abnormal |
4.4% |
| Muscular Weakness |
4.4% |
| Nausea |
4.4% |
| Off Label Use |
4.4% |
| Renal Impairment |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Vomiting |
4.4% |
| White Blood Cells Urine Positive |
4.4% |
| Cardiac Failure |
2.9% |
| Dermatitis Bullous |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
|
